Epithelioid sarcoma is a rare type of mesenchymal tumor characterized by aggressive behavior and high metastatic capacity. The bulk of this tumor is made up of epithelioid cells, which can be found in soft tissues and bones. Epithelioid sarcoma most often affects young people and adults aged 20 to 40 years. Externally, this tumor can take the form of a tumor formation resembling fibrosarcoma or carcinoma, which complicates its diagnosis and requires a differential approach. The pathogenesis of epithelioid sarcoma remains poorly understood. However, there is evidence of the influence of mutations in certain genes and environmental factors on the development of this disease.
History of the disease and interesting historical facts
Historically, epithelioid sarcoma was first described in the early 20th century. In 1928, scientist J. Watson identified this type of tumor as a separate nosological entity, which contributed to further study of its morphology and pathogenesis. It is interesting to note that until the 1940s, epithelioid sarcoma did not receive due attention from the scientific community, and many cases were mistakenly classified as fibrosarcomas. Later, in the 1970s, active research began, which allowed a more in-depth understanding of the characteristics of the disease and its relationship with various risk factors.
Epidemiology
According to statistics, epithelioid sarcoma is a rare disease. According to the study, the prevalence of this type of sarcoma is less than 1% of the total number of all soft tissue sarcomas. Based on large registries, such as SEER (Surveillance, Epidemiology, and End Results), it is shown that less than 0.5 cases of epithelioid sarcoma are registered per 1 million people per year. The disease is more common in young people, and men are more susceptible to this disease than women. However, sexual dimorphism in the incidence is not so pronounced, which makes this tumor more mysterious.
Genetic predisposition to this disease
Epithelioid sarcoma is associated with mutations in certain genes that may predispose to its development. In particular, mutations have been identified in the TP53 and EWSR1 genes, which play a key role in cell cycle regulation and apoptosis. According to a study published in the Journal of Clinical Oncology, about 60% patients with epithelioid sarcoma have abnormalities in a number of genes associated with the cellular signal pathway, which also confirms their role in the pathogenesis of this disease. There is an opinion that hereditary syndromes, such as Li-Fraumeni syndrome, may increase the risk of developing epithelioid sarcoma in individual patients.
Risk factors for the development of this disease
Risk factors for the development of epithelioid sarcoma can be both physical and chemical. These include:
- Long-term exposure to ionizing radiation.
- Exposure to certain chemical carcinogens, such as asbestos and formaldehyde.
- The presence of chronic inflammatory diseases.
- Hereditary predisposition to soft tissue tumors.
Some researchers also point to a possible link between trauma and tumor development, although this issue requires further study.
Diagnosis of this disease
Diagnosis of epithelioid sarcoma includes several stages, each of which uses different research methods. The main symptoms of the disease may include:
- Formation of a soft tissue tumor that is firm to the touch.
- Pain in the area of the tumor (if nerve structures are involved).
- Limitation of movement in adjacent joints.
Laboratory tests may include:
- Histological examination of tumor biopsy.
- Immunohistochemical analysis to detect specific markers.
Radiological examinations such as ultrasound, CT or MRI play an important role in determining the stage of the disease and the extent of the process. Differential diagnosis is necessary to exclude other types of sarcomas and tumors, which requires careful analysis of the clinical picture.
Treatment
Treatment of epithelioid sarcoma is based on a comprehensive approach and includes surgery, radiation and chemotherapy. Surgical treatment is the main method aimed at complete removal of the tumor with the capture of surrounding healthy tissue. Pharmacological treatment may include:
- Chemotherapeutic drugs such as dossexa, doxorubicin.
- Immunotherapy methods if the tumor is resistant to chemotherapy drugs.
Radiotherapy can be used in both adjuvant and neoadjuvant settings, especially in patients with high risk of recurrence. Recently, there has been an increase in the use of molecular target therapies, which gives hope for improving the prognosis of patients with metastatic disease.
List of drugs used to treat this disease
Oncologists have the following medications in their arsenal for treating epithelioid sarcoma:
- Doxorubicin (Adriamycin)
- Ifosfamide
- Dacetaxel
- Gemcitabine
- Paclitaxel
These drugs are often combined to achieve maximum effect.
Disease monitoring
Monitoring of a patient with epithelioid sarcoma includes regular visits to an oncologist, as well as periodic radiological examinations to detect recurrences or metastases. The prognosis of the disease depends on factors such as the degree of differentiation of the tumor, the presence of metastases at the time of diagnosis, and the success of the treatment. Complications may include recurrence of the disease and the need for repeated surgical interventions.
Age-related features of the disease
Epithelioid sarcoma is more common in young people aged 20-40 years, but can also be observed in older people. In children, this tumor is extremely rare and is often associated with hereditary syndromes. In elderly patients, manifestations may be less aggressive, but the risk of concomitant diseases is high.
Questions and Answers
- What are the main symptoms of epithelioid sarcoma? The main symptoms include the presence of a painless swelling, often firm to the touch, as well as pain and limitation of movement depending on the location of the swelling.
- How is epithelioid sarcoma treated? Treatment includes surgery, chemotherapy and radiation therapy, and the choice of strategy depends on the stage and location of the tumor.
- What is the life expectancy for epithelioid sarcoma? The prognosis depends on many factors, including the stage of the disease and the success of treatment, but the course is dangerous due to the high probability of relapse.
- What are the risk factors for the disease? Risk factors include long-term exposure to carcinogens, ionizing radiation and a hereditary predisposition.
- How are diagnostic tests performed? Diagnostics includes biopsy, histological examination, immunohistochemistry and various instrumental methods (ultrasound, MRI, CT).
Advice from Dr. Oleg Korzhikov
If you have a tumor, it is important not to delay a visit to the doctor; early diagnosis significantly increases the chances of successful treatment. If you experience pain or changes in your health without any apparent reason, be sure to consult a specialist. It is also important to monitor your general condition and undergo regular examinations if you have bad habits or chronic diseases that can increase the risk of developing tumors. A reasonable approach to prevention and careful attention to your health are key factors in the fight against epithelioid sarcoma.
